Rebapatide can be checked for Helicobacter pylori 1 week after stopping the drug.
Rebapatide tablets are a treatment for gastric mucosal lesions caused by acute exacerbation of chronic gastritis, which can improve symptoms such as gastric hemorrhage, gastric erosion and gastric edema.
The drug has the effect of protecting the gastric mucosal barrier, and does not have a killing effect on Helicobacter pylori itself, so the examination of Helicobacter pylori can usually be carried out after stopping the drug for 1 week.
Common adverse effects of the drug include constipation, nausea, vomiting, belching, abdominal pain, cough, dyspnea, rash, urticaria, and drowsiness. The drug should be used with caution in pregnant women as well as infants.
The drug should be used under the supervision of a doctor and should not be used blindly on its own.